(Q37854748)

24 August 2017

1 reference

title

Acotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsia (English)

1 reference

24 August 2017

Jan Tack

1

1 reference

24 August 2017

Pieter Janssen

series ordinal

2

1 reference

24 August 2017

language of work or name

English

0 references

publication date

22 March 2011

1 reference

Expert Opinion on Investigational Drugs

24 August 2017

published in

1 reference

24 August 2017

volume

20

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

701-712

1 reference

Functional gastroduodenal disorders

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.562890

Functional dyspepsia impacts absenteeism and direct and indirect costs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.562890

Pathophysiology and treatment of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.562890

Promotility medications--now and in the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.562890

Prokinetics and fundic relaxants in upper functional GI disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.562890

Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.562890

Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.562890

Characterization of functional effects of Z-338, a novel gastroprokinetic agent, on the muscarinic M1, M2, and M3 receptors expressed in Xenopus oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.562890

Impaired gastric accommodation and its role in dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.562890

Acotiamide hydrochloride (Z-338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.562890

A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.562890

Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.562890

Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.562890

Cholinergic effects on human gastric motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.562890

Neostigmine-Induced Postprandial Phasic Contractility in the Proximal Stomach and Dyspepsia-Like Symptoms in Healthy Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.562890

Pharmacological interventions for non-ulcer dyspepsia

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001960.PUB3

Identifiers

DOI

10.1517/13543784.2011.562890

1 reference

24 August 2017

1 reference